Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

Slides:

Advertisements

Similar presentations

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Advertisements

Clinical Application of Nasal Filters: An Observational Study on the Usability of Nasal Filters in Managing Seasonal Allergic Rhinitis Peter Kenney,

The Journal of Allergy and Clinical Immunology: In Practice

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists Michael H. Land, MD, Julie Wang, MD

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

Advances in Diagnosing Peanut Allergy

Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis Andrzej Bożek, MD, PhD, Krzysztof Kołodziejczyk, MD, PhD, Jerzy Jarząb,

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo Eli O. Meltzer, MD, Claus Bachert,

Pharmacologic rationale for treating allergic and nonallergic rhinitis

Aleena Banerji, MD, Kimberly G. Blumenthal, MD, MSc, Kenneth H

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients Eli O. Meltzer, MD, Judith.

Vitamin D Insufficiency and Asthma in a US Nationwide Study

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Luciana Kase Tanno, MD, PhD, Moises A

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Chronic Rhinosinusitis

Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed Leonard Bielory, MD The Journal of Allergy and Clinical Immunology:

Wells Syndrome with Bullous Lesions

Dennis K. Ledford, MD, Sally Wenzel, MD

Jennie Gane, MBChB (Hons), MSc, Roger Buckley, BM BCh, MA, FRCS

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Is 9 more than 2 also in allergic airway inflammation?

Desensitization to Chemotherapeutic Agents

Clinical Application of Nasal Filters: An Observational Study on the Usability of Nasal Filters in Managing Seasonal Allergic Rhinitis Peter Kenney,

Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Robert G. Hamilton, PhD, John Oppenheimer, MD

Anita Sivam, DO, Mike Tankersley, MD, MBA

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

Advances in Diagnosing Peanut Allergy

Self-Medication in Persistent Rhinitis: Overuse of Decongestants in Half of the Patients Els Mehuys, MPharm, PhD, Philippe Gevaert, MD, PhD, Guy Brusselle,

Nonadherence to Asthma Treatment: Getting Unstuck

Successful treatment of idiopathic angioedema with ecallantide

Reply The Journal of Allergy and Clinical Immunology: In Practice

Aimee L. Speck, MD, Michael Hess, MSI, Alan P. Baptist, MD, MPH

Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2 Phillip Lieberman, MD The Journal of Allergy.

Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population Stephanie J. Fox, MD, Miguel A. Park,

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

Phillip Lieberman, MD, Michael Tankersley, MD

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

The Management of Eosinophilic Esophagitis

Phillip Lieberman, MD, David Golden, MD

Russell S. Traister, MD, PhD, Merritt L

Biosimilars and drug development in allergic and immunologic diseases

Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase Phillip Lieberman, MD, Lawrence B. Schwartz, MD,

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma Oliver.

Allergen-specific immunotherapy with recombinant grass pollen allergens Marek Jutel, MD, Lothar Jaeger, MD, Roland Suck, PhD, Hanns Meyer, Dipl Math,

International Study of Risk-Mitigating Factors and In-Flight Allergic Reactions to Peanut and Tree Nut Matthew Greenhawt, MD, MBA, MSc, Fiona MacGillivray,

Neetu Talreja, MD, Richard F. Lockey, MD

Sinonasal Papillomas and Natural Killer–Cell Deficiency

Sharon Seth, MD, David A. Khan, MD

Cephalosporin Side Chain Cross-reactivity

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo Eli O. Meltzer, MD, Claus Bachert,

Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency Phil Lieberman, MD, John Routes, MD The Journal.

Reply The Journal of Allergy and Clinical Immunology: In Practice

An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment Eli O. Meltzer, MD, Robert B. Berkowitz,

Footnotes1 Journal of Allergy and Clinical Immunology

Macrolide antibiotics and asthma treatment

Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis Warner Carr, MD, Jonathan Bernstein, MD, Phil Lieberman,

The effects of an H3 receptor antagonist (PF ) with fexofenadine on reducing allergic rhinitis symptoms Jeffrey R. Stokes, MD, Francisco A. Romero,

An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment Eli O. Meltzer, MD, Robert B. Berkowitz,

Natural history of cow’s milk allergy

Presentation transcript:

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul H. Ratner, MD, MBA, Thomas McGraw, PhD The Journal of Allergy and Clinical Immunology: In Practice Volume 3, Issue 5, Pages 702-708 (September 2015) DOI: 10.1016/j.jaip.2015.05.007 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 1 Disposition of participants. The ITT population included all participants who were randomized to a study treatment. The safety population included all participants who took at least 1 dose of study medication. The EE population (ie, those analyzed) included all participants in the ITT population who had at least 1 complete full day (morning and evening) of postdose reflective nasal congestion symptom scores. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 702-708DOI: (10.1016/j.jaip.2015.05.007) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 2 Reflective nasal congestion scores by treatment and study day (ITT population). Because the y-axis does not begin from 0, the figure may exaggerate the placebo effect of the first dose. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 702-708DOI: (10.1016/j.jaip.2015.05.007) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions